Does Dr. MADELINE ASENCIO-MONTALVO have financial conflicts of interest?

Dr. MADELINE ASENCIO-MONTALVO (MD) has received a total of $520 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $520 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MADELINE ASENCIO-MONTALVO?

According to CMS Open Payments data, Dr. MADELINE ASENCIO-MONTALVO received funding from LILLY USA ($274), ABBVIE ($104), and ASTRAZENECA PHARMACEUTICALS ($67).

Does Dr. MADELINE ASENCIO-MONTALVO receive research grants or speaking fees?

Dr. MADELINE ASENCIO-MONTALVO has received $520 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MADELINE ASENCIO-MONTALVO

MDReal-Time Hydrated

Specialty: General Practice

Practice Location: CABO ROJO, PR 00623

NPI Number: 1538235247

LIFETIME INDUSTRY VALUE

$520

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ASENCIO-MONTALVO is a verified General Practice practitioner based in CABO ROJO, PR.

Between 2021 and 2025, Dr. ASENCIO-MONTALVO had an overall industry promotional and research financial footprint of $520 as recorded in the federal CMS Open Payments database.

$520 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ASENCIO-MONTALVO's primary funding source is LILLY USA, which accounts for $274 (representing 52.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

LILLY USA

Rank 1

$274

52.8%

ABBVIE

Rank 2

$104

20.1%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$67

12.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.